{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:51:26Z","timestamp":1781941886443,"version":"3.54.5"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) is a highly heterogeneous, invasive brain tumor with profound metabolic plasticity. Patient-derived cultures provide valuable preclinical models, yet the stability and clinical relevance of their metabolic phenotypes during ex vivo maintenance remain unclear. Here, we performed longitudinal functional profiling of mitochondrial respiration, substrate utilization, and migration in primary patient-derived GBM cultures at one and five weeks ex vivo using Seahorse Bioanalyzer assays and wound-healing assays, complemented by exploratory integration with routine clinical parameters (MGMT promoter methylation, p53 expression, sex, and age). Early profiling identified two mitochondrial subgroups distinguished by spare and maximal respiratory capacity, with MGMT promoter methylation observed exclusively in the high-respiration cluster. Over time, most cultures retained their initial phenotype, whereas a subset transitioned from low to high respiration, indicating dynamic adaptation under standardized conditions. Extended culture was accompanied by patient-specific shifts in fuel utilization, including increased glutamine dependency and reduced inter-sample variability in glucose and fatty-acid parameters. Exploratory analyses suggested an association between higher age and lower fatty-acid oxidation capacity and indicated constrained fatty-acid dependency in p53-positive cultures. Migration assays revealed marked inter-sample heterogeneity and a 2\u20136 times faster gap closure in male-derived than female-derived cultures. Notably, early migratory behavior showed no strong association with OCR-defined metabolic state, and early fuel-flex parameters did not recapitulate OCR cluster structure. Together, these data provide a standardized longitudinal functional benchmark showing that patient-derived GBM cultures preserve intrinsic metabolic heterogeneity while undergoing time-dependent adaptation, and that migration represents an additional, partially independent functional axis. These findings are hypothesis-generating and support stratified, time-sensitive follow-up studies of metabolic and invasive phenotypes in GBM.<\/jats:p>","DOI":"10.1186\/s40478-026-02349-0","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:27:51Z","timestamp":1781796471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-derived glioblastoma cultures preserve respiration phenotypes during ex vivo maintenance and show sex-associated differences in migration"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9717-4485","authenticated-orcid":false,"given":"Veronika","family":"Matschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lucaciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pickmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Theiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4878-8741","authenticated-orcid":false,"given":"Johann","family":"Matschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"2349_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"2349_CR2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa043330","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. https:\/\/doi.org\/10.1056\/nejmoa043330","journal-title":"N Engl J Med"},{"key":"2349_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072116","author":"SSK Yalamarty","year":"2023","unstructured":"Yalamarty SSK, Filipczak N, Li X, Subhan MA, Parveen F, Ataide JA et al (2023) Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM). Cancers. https:\/\/doi.org\/10.3390\/cancers15072116","journal-title":"Cancers"},{"key":"2349_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.703764","author":"A Comba","year":"2021","unstructured":"Comba A, Faisal SM, Varela ML, Hollon T, Al-Holou WN, Umemura Y et al (2021) Uncovering spatiotemporal heterogeneity of high-grade gliomas: from disease biology to therapeutic implications. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.703764","journal-title":"Front Oncol"},{"key":"2349_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03569-w","author":"CE Badr","year":"2020","unstructured":"Badr CE, Silver DJ, Siebzehnrubl FA, Deleyrolle LP (2020) Metabolic heterogeneity and adaptability in brain tumors. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-020-03569-w","journal-title":"Cell Mol Life Sci"},{"key":"2349_CR6","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016218117251","author":"A Korshunov","year":"2002","unstructured":"Korshunov A, Golanov A, Sycheva R (2002) Immunohistochemical markers for prognosis of cerebral glioblastomas. J Neurooncol. https:\/\/doi.org\/10.1023\/A:1016218117251","journal-title":"J Neurooncol"},{"key":"2349_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04127-5","author":"R Uceda-Castro","year":"2022","unstructured":"Uceda-Castro R, van Asperen JV, Vennin C, Sluijs JA, van Bodegraven EJ, Margarido AS et al (2022) GFAP splice variants fine-tune glioma cell invasion and tumour dynamics by modulating migration persistence. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-021-04127-5","journal-title":"Sci Rep"},{"key":"2349_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95958-9","author":"RH Dahlrot","year":"2021","unstructured":"Dahlrot RH, Bangs\u00f8 JA, Petersen JK, Rosager AM, S\u00f8rensen MD, Reifenberger G et al (2021) Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-021-95958-9","journal-title":"Sci Rep"},{"key":"2349_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-022-03955-3","author":"W Haque","year":"2022","unstructured":"Haque W, Teh C, Butler EB, Teh BS (2022) Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-022-03955-3","journal-title":"J Neurooncol"},{"key":"2349_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2018.1487953","author":"S Haase","year":"2018","unstructured":"Haase S, Garcia-Fabiani MB, Carney S, Altshuler D, N\u00fa\u00f1ez FJ, M\u00e9ndez FM et al (2018) Mutant ATRX: uncovering a new therapeutic target for glioma. Expert Opin Ther Targets. https:\/\/doi.org\/10.1080\/14728222.2018.1487953","journal-title":"Expert Opin Ther Targets"},{"key":"2349_CR11","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0218","author":"M Labussiere","year":"2010","unstructured":"Labussiere M, Sanson M, Idbaih A, Delattre JY (2010) IDH1 gene mutations: a new paradigm in glioma prognosis and therapy? Oncologist. https:\/\/doi.org\/10.1634\/theoncologist.2009-0218","journal-title":"Oncologist"},{"key":"2349_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010102","author":"V Ramar","year":"2024","unstructured":"Ramar V, Guo S, Hudson BA, Liu M (2024) Progress in glioma stem cell research. Cancers. https:\/\/doi.org\/10.3390\/cancers16010102","journal-title":"Cancers"},{"key":"2349_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/gad.350693.123","author":"SJ de Ruiter","year":"2023","unstructured":"de Ruiter SJ, Michalopoulou E, Noch EK, Lukey MJ, Van Aelst L (2023) Metabolic partitioning in the brain and its hijacking by glioblastoma. Genes Dev. https:\/\/doi.org\/10.1101\/gad.350693.123","journal-title":"Genes Dev"},{"key":"2349_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12535","author":"K Masui","year":"2019","unstructured":"Masui K, Onizuka H, Cavenee WK, Mischel PS, Shibata N (2019) Metabolic reprogramming in the pathogenesis of glioma: update. Neuropathology. https:\/\/doi.org\/10.1111\/neup.12535","journal-title":"Neuropathology"},{"key":"2349_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091231","author":"W Zhou","year":"2019","unstructured":"Zhou W, Wahl DR (2019) Metabolic abnormalities in glioblastoma and metabolic strategies to overcome treatment resistance. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11091231","journal-title":"Cancers (Basel)"},{"key":"2349_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/pin.13379","author":"K Masui","year":"2023","unstructured":"Masui K, Mischel PS (2023) Metabolic and epigenetic reprogramming in the pathogenesis of glioblastoma: toward the establishment of \u201cmetabolism-based pathology.\u201d Pathol Int. https:\/\/doi.org\/10.1111\/pin.13379","journal-title":"Pathol Int"},{"key":"2349_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0226-5","author":"J Bi","year":"2020","unstructured":"Bi J, Chowdhry S, Wu S, Zhang W, Masui K, Mischel PS (2020) Altered cellular metabolism in gliomas\u2014an emerging landscape of actionable co-dependency targets. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/s41568-019-0226-5","journal-title":"Nat Rev Cancer"},{"key":"2349_CR18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0844","author":"SM Fendt","year":"2020","unstructured":"Fendt SM, Frezza C, Erez A (2020) Targeting metabolic plasticity and flexibility dynamics for cancer therapy. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0844","journal-title":"Cancer Discov"},{"key":"2349_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55296-3","author":"R Shiratori","year":"2019","unstructured":"Shiratori R, Furuichi K, Yamaguchi M, Miyazaki N, Aoki H, Chibana H et al (2019) Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-55296-3","journal-title":"Sci Rep"},{"key":"2349_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1091779","author":"D Zhou","year":"2022","unstructured":"Zhou D, Duan Z, Li Z, Ge F, Wei R, Kong L (2022) The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1091779","journal-title":"Front Pharmacol"},{"key":"2349_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.412","author":"D Anastasiou","year":"2017","unstructured":"Anastasiou D (2017) Tumour microenvironment factors shaping the cancer metabolism landscape. Br J Cancer. https:\/\/doi.org\/10.1038\/bjc.2016.412","journal-title":"Br J Cancer"},{"key":"2349_CR22","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7013.1000211","author":"VK Ramanujan","year":"2015","unstructured":"Ramanujan VK (2015) Metabolic plasticity in cancer cells: reconnecting mitochondrial function to cancer control. J Cell Sci Ther. https:\/\/doi.org\/10.4172\/2157-7013.1000211","journal-title":"J Cell Sci Ther"},{"key":"2349_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09460-7","author":"AJ Scott","year":"2025","unstructured":"Scott AJ, Mittal A, Meghdadi B, O\u2019Brien A, Bailleul J, Sravya P et al (2025) Rewiring of cortical glucose metabolism fuels human brain cancer growth. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09460-7","journal-title":"Nature"},{"key":"2349_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164058","author":"B Behnam","year":"2023","unstructured":"Behnam B, Taghizadeh-Hesary F (2023) Mitochondrial metabolism: a new dimension of personalized oncology. Cancers. https:\/\/doi.org\/10.3390\/cancers15164058","journal-title":"Cancers"},{"key":"2349_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1254313","author":"KE Pendleton","year":"2023","unstructured":"Pendleton KE, Wang K, Echeverria GV (2023) Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2023.1254313","journal-title":"Front Cell Dev Biol"},{"key":"2349_CR26","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20193","author":"PF Ledur","year":"2017","unstructured":"Ledur PF, Onzi GR, Zong H, Lenz G (2017) Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries? Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.20193","journal-title":"Oncotarget"},{"key":"2349_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6853","author":"M Allen","year":"2016","unstructured":"Allen M, Bjerke M, Edlund H, Nelander S, Westermark B (2016) Origin of the U87MG glioma cell line: good news and bad news. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6853","journal-title":"Sci Transl Med"},{"key":"2349_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51214-y","author":"M Wu","year":"2024","unstructured":"Wu M, Wang T, Ji N, Lu T, Yuan R, Wu L et al (2024) Multi-omics and pharmacological characterization of patient-derived glioma cell lines. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-024-51214-y","journal-title":"Nat Commun"},{"key":"2349_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02380-1","author":"R Kumar","year":"2017","unstructured":"Kumar R, Gont A, Perkins TJ, Hanson JEL, Lorimer IAJ (2017) Induction of senescence in primary glioblastoma cells by serum and TGF\u03b2. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-02380-1","journal-title":"Sci Rep"},{"key":"2349_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.03.030","author":"J Lee","year":"2006","unstructured":"Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccr.2006.03.030","journal-title":"Cancer Cell"},{"key":"2349_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210949","author":"HS G\u00fcnther","year":"2008","unstructured":"G\u00fcnther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R et al (2008) Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene. https:\/\/doi.org\/10.1038\/sj.onc.1210949","journal-title":"Oncogene"},{"issue":"1","key":"2349_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-024-01805-x","volume":"10","author":"K Xiang","year":"2024","unstructured":"Xiang K, Kunin M, Larafa S, Busch M, D\u00fcnker N, Jendrossek V et al (2024) \u03b1-Ketoglutarate supplementation and NAD+ modulation enhance metabolic rewiring and radiosensitization in SLC25A1 inhibited cancer cells. Cell Death Discov 10(1):1\u201314. https:\/\/doi.org\/10.1038\/s41420-024-01805-x","journal-title":"Cell Death Discov"},{"issue":"7","key":"2349_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05098-9","volume":"13","author":"K Xiang","year":"2022","unstructured":"Xiang K, Kalthoff C, M\u00fcnch C, Jendrossek V, Matschke J (2022) Accumulation of oncometabolite D-2-Hydroxyglutarate by SLC25A1 inhibition: a metabolic strategy for induction of HR-ness and radiosensitivity. Cell Death Dis 13(7):1\u201312. https:\/\/doi.org\/10.1038\/s41419-022-05098-9","journal-title":"Cell Death Dis"},{"issue":"11","key":"2349_CR34","doi-asserted-by":"publisher","first-page":"103366","DOI":"10.1016\/j.isci.2021.103366","volume":"24","author":"A Krysztofiak","year":"2021","unstructured":"Krysztofiak A, Szymonowicz K, Hlouschek J, Xiang K, Waterkamp C, Larafa S et al (2021) Metabolism of cancer cells commonly responds to irradiation by a transient early mitochondrial shutdown. iScience 24(11):103366. https:\/\/doi.org\/10.1016\/j.isci.2021.103366","journal-title":"iScience"},{"issue":"1","key":"2349_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-023-01695-5","volume":"9","author":"Y Henning","year":"2023","unstructured":"Henning Y, Willbrand K, Larafa S, Wei\u00dfenberg G, Matschke V, Theiss C et al (2023) Cigarette smoke causes a bioenergetic crisis in RPE cells involving the downregulation of HIF-1\u03b1 under normoxia. Cell Death Discov 9(1):1\u201311. https:\/\/doi.org\/10.1038\/s41420-023-01695-5","journal-title":"Cell Death Discov"},{"issue":"MAY","key":"2349_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2018.00170\/BIBTEX","volume":"8","author":"J Hlouschek","year":"2018","unstructured":"Hlouschek J, Hansel C, Jendrossek V, Matschke J (2018) The mitochondrial citrate carrier (SLC25A1) sustains redox homeostasis and mitochondrial metabolism supporting radioresistance of cancer cells with tolerance to cycling severe hypoxia. Front Oncol 8(MAY):366331. https:\/\/doi.org\/10.3389\/FONC.2018.00170\/BIBTEX","journal-title":"Front Oncol"},{"key":"2349_CR37","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2021."},{"key":"2349_CR38","unstructured":"Hadley W. Ggplot2: elegant graphics for data analysis. J Stat Softw. 2029;35."},{"key":"2349_CR39","unstructured":"Goodrich B, Gabry J, Brilleman S. R package version. rstanarm: Bayesian Applied Regression Modeling via Stan. 2019."},{"key":"2349_CR40","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v076.i01","author":"B Carpenter","year":"2017","unstructured":"Carpenter B, Gelman A, Hoffman MD, Lee D, Goodrich B, Betancourt M et al (2017) Stan: a probabilistic programming language. J Stat Softw. https:\/\/doi.org\/10.18637\/jss.v076.i01","journal-title":"J Stat Softw"},{"issue":"1","key":"2349_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","volume":"20","author":"J Bi","year":"2020","unstructured":"Bi J, Chowdhry S, Wu S, Zhang W, Masui K, Mischel PS (2020) Altered cellular metabolism in gliomas\u2014an emerging landscape of actionable co-dependency targets. Nat Rev Cancer 20(1):57\u201370. https:\/\/doi.org\/10.1038\/s41568-019-0226-5","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2349_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/CELLS10020202","volume":"10","author":"T Duraj","year":"2021","unstructured":"Duraj T, Garc\u00eda-romero N, Carri\u00f3n-navarro J, Madurga R, de Mendivil AO, Prat-acin R et al (2021) Beyond the warburg effect: oxidative and glycolytic phenotypes coexist within the metabolic heterogeneity of glioblastoma. Cells 10(2):202. https:\/\/doi.org\/10.3390\/CELLS10020202. (PubMed PMID: 33498369)","journal-title":"Cells"},{"issue":"4","key":"2349_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2449-5","volume":"11","author":"S Kant","year":"2020","unstructured":"Kant S, Kesarwani P, Prabhu A, Graham SF, Buelow KL, Nakano I et al (2020) Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment. Cell Death Dis 11(4):1\u201313. https:\/\/doi.org\/10.1038\/s41419-020-2449-5","journal-title":"Cell Death Dis"},{"issue":"15","key":"2349_CR44","doi-asserted-by":"publisher","first-page":"1368685","DOI":"10.3389\/FIMMU.2024.1368685\/BIBTEX","volume":"6","author":"P Liu","year":"2024","unstructured":"Liu P, Xing N, Xiahou Z, Yan J, Lin Z, Zhang J (2024) Unraveling the intricacies of glioblastoma progression and recurrence: insights into the role of NFYB and oxidative phosphorylation at the single-cell level. Front Immunol 6(15):1368685. https:\/\/doi.org\/10.3389\/FIMMU.2024.1368685\/BIBTEX. (PubMed PMID: 38510250)","journal-title":"Front Immunol"},{"key":"2349_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab269","author":"YA Yabo","year":"2022","unstructured":"Yabo YA, Niclou SP, Golebiewska A (2022) Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab269","journal-title":"Neuro Oncol"},{"key":"2349_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-00159-4","author":"L Garofano","year":"2021","unstructured":"Garofano L, Migliozzi S, Oh YT, D\u2019Angelo F, Najac RD, Ko A et al (2021) Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities. Nat Cancer. https:\/\/doi.org\/10.1038\/s43018-020-00159-4","journal-title":"Nat Cancer"},{"issue":"502","key":"2349_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/J.CANLET.2020.12.020","volume":"1","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC, San MA (2021) Metabolic adaptation in hypoxia and cancer. Cancer Lett 1(502):133\u2013142. https:\/\/doi.org\/10.1016\/J.CANLET.2020.12.020. (PubMed PMID: 33444690)","journal-title":"Cancer Lett"},{"issue":"8","key":"2349_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/METABO14080413\/S1","volume":"14","author":"A Bezawork-Geleta","year":"2024","unstructured":"Bezawork-Geleta A, Moujalled D, De Souza DP, Narayana VK, Dimou J, Luwor R et al (2024) Metabolic plasticity of glioblastoma cells in response to DHODH inhibitor BAY2402234 treatment. Metabolites 14(8):413. https:\/\/doi.org\/10.3390\/METABO14080413\/S1","journal-title":"Metabolites"},{"issue":"10","key":"2349_CR49","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1096\/FJ.202000767R","volume":"34","author":"P Marchetti","year":"2020","unstructured":"Marchetti P, Fovez Q, Germain N, Khamari R, Kluza J (2020) Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells. FASEB J 34(10):13106\u201313124. https:\/\/doi.org\/10.1096\/FJ.202000767R. (PubMed PMID: 32808332)","journal-title":"FASEB J"},{"key":"2349_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/S00018-025-05641-9","author":"A Narayanan","year":"2025","unstructured":"Narayanan A, Saurty-Seerunghen MS, Michieletto J, Delaunay V, Bruneel A, Dupr\u00e9 T et al (2025) Nicotinamide metabolism reprogramming drives reversible senescence of glioblastoma cells. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/S00018-025-05641-9","journal-title":"Cell Mol Life Sci"},{"issue":"13","key":"2349_CR51","doi-asserted-by":"publisher","first-page":"1535073","DOI":"10.3389\/FCELL.2025.1535073\/PDF","volume":"26","author":"S D\u2019Aprile","year":"2025","unstructured":"D\u2019Aprile S, Denaro S, Gervasi A, Vicario N, Parenti R (2025) Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance. Front Cell Dev Biol 26(13):1535073. https:\/\/doi.org\/10.3389\/FCELL.2025.1535073\/PDF","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2349_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/NEUONC\/NOV125","volume":"18","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S, Zadeh G (2016) Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions. Neuro Oncol 18(2):160\u2013172. https:\/\/doi.org\/10.1093\/NEUONC\/NOV125. (PubMed PMID: 26180081)","journal-title":"Neuro Oncol"},{"issue":"18","key":"2349_CR53","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/CELLS13181574","volume":"13","author":"AI Cortes Ballen","year":"2024","unstructured":"Cortes Ballen AI, Amosu M, Ravinder S, Chan J, Derin E, Slika H et al (2024) Metabolic reprogramming in glioblastoma multiforme: a review of pathways and therapeutic targets. Cells 13(18):1574. https:\/\/doi.org\/10.3390\/CELLS13181574","journal-title":"Cells"},{"issue":"9","key":"2349_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2021.683276\/PDF","volume":"1","author":"JH Garcia","year":"2021","unstructured":"Garcia JH, Jain S, Aghi MK (2021) Metabolic drivers of invasion in glioblastoma. Front Cell Dev Biol 1(9):683276. https:\/\/doi.org\/10.3389\/FCELL.2021.683276\/PDF","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2349_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-03383-z","volume":"12","author":"ML Kamradt","year":"2021","unstructured":"Kamradt ML, Jung JU, Pflug KM, Lee DW, Fanniel V, Sitcheran R (2021) NIK promotes metabolic adaptation of glioblastoma cells to bioenergetic stress. Cell Death Dis 12(3):1\u201318. https:\/\/doi.org\/10.1038\/s41419-020-03383-z","journal-title":"Cell Death Dis"},{"issue":"OCT","key":"2349_CR56","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/FGENE.2018.00427","volume":"9","author":"V Miranda-Gon\u00e7alves","year":"2018","unstructured":"Miranda-Gon\u00e7alves V, Lameirinhas A, Henrique R, Jer\u00f3nimo C (2018) Metabolism and epigenetic interplay in cancer: regulation and putative therapeutic targets. Front Genet 9(OCT):427. https:\/\/doi.org\/10.3389\/FGENE.2018.00427","journal-title":"Front Genet"},{"issue":"7","key":"2349_CR57","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"X Xu","year":"2023","unstructured":"Xu X, Peng Q, Jiang X, Tan S, Yang Y, Yang W et al (2023) Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp Mol Med 55(7):1357\u20131370. https:\/\/doi.org\/10.1038\/s12276-023-01020-1","journal-title":"Exp Mol Med"},{"key":"2349_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/membranes11070465","author":"F Joubert","year":"2021","unstructured":"Joubert F, Puff N (2021) Mitochondrial cristae architecture and functions: lessons from minimal model systems. Membranes. https:\/\/doi.org\/10.3390\/membranes11070465","journal-title":"Membranes"},{"key":"2349_CR59","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169868","author":"J Chen","year":"2023","unstructured":"Chen J, Zheng Q, Hicks JL, Trabzonlu L, Ozbek B, Jones T et al (2023) MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.169868","journal-title":"JCI Insight"},{"key":"2349_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2020.06.004","author":"CA Castellani","year":"2020","unstructured":"Castellani CA, Longchamps RJ, Sun J, Guallar E, Arking DE (2020) Thinking outside the nucleus: mitochondrial DNA copy number in health and disease. Mitochondrion. https:\/\/doi.org\/10.1016\/j.mito.2020.06.004","journal-title":"Mitochondrion"},{"key":"2349_CR61","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2022.0173","author":"P Je\u017eek","year":"2023","unstructured":"Je\u017eek P, Jab\u016frek M, Holendov\u00e1 B, Engstov\u00e1 H, Dlaskov\u00e1 A (2023) Mitochondrial cristae morphology reflecting metabolism, superoxide formation, redox homeostasis, and pathology. Antioxid Redox Signal. https:\/\/doi.org\/10.1089\/ars.2022.0173","journal-title":"Antioxid Redox Signal"},{"key":"2349_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137038","author":"G Sharapova","year":"2024","unstructured":"Sharapova G, Sabirova S, Gomzikova M, Brichkina A, Barlev NA, Kalacheva NV et al (2024) Mitochondrial protein density, biomass, and bioenergetics as predictors for the efficacy of glioma treatments. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137038","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2349_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-21927-4","volume":"8","author":"Q Li","year":"2018","unstructured":"Li Q, Lin H, Rauch J, Deleyrolle LP, Reynolds BA, Viljoen HJ et al (2018) Scalable culturing of primary human glioblastoma tumor-initiating cells with a cell-friendly culture system. Sci Rep 8(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-018-21927-4","journal-title":"Sci Rep"},{"key":"2349_CR64","doi-asserted-by":"publisher","first-page":"51088","DOI":"10.3791\/51088","volume":"83","author":"LA Hasselbach","year":"2014","unstructured":"Hasselbach LA, Irtenkauf SM, Lemke NW, Nelson KK, Berezovsky AD, Carlton ET et al (2014) Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistry. J Vis Exp 83:51088. https:\/\/doi.org\/10.3791\/51088. (PubMed PMID: 24429465)","journal-title":"J Vis Exp"},{"issue":"37","key":"2349_CR65","doi-asserted-by":"publisher","first-page":"32843","DOI":"10.1074\/JBC.M111.260935","volume":"286","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Zhou Y, Shingu T, Feng L, Chen Z, Ogasawara M et al (2011) Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis. J Biol Chem 286(37):32843. https:\/\/doi.org\/10.1074\/JBC.M111.260935. (PubMed PMID: 21795717)","journal-title":"J Biol Chem"},{"issue":"38","key":"2349_CR66","doi-asserted-by":"publisher","first-page":"16062","DOI":"10.1073\/PNAS.1106704108","volume":"108","author":"E Vlashi","year":"2011","unstructured":"Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M et al (2011) Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci USA 108(38):16062\u201316067. https:\/\/doi.org\/10.1073\/PNAS.1106704108","journal-title":"Proc Natl Acad Sci USA"},{"key":"2349_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/oons\/kvad008","author":"X Wang","year":"2023","unstructured":"Wang X, Sun Y, Zhang DY, Ming GL, Song H (2023) Glioblastoma modeling with 3D organoids: progress and challenges. Oxford Open Neurosci. https:\/\/doi.org\/10.1093\/oons\/kvad008","journal-title":"Oxford Open Neurosci"},{"key":"2349_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04536-8","author":"N Yadav","year":"2024","unstructured":"Yadav N, Purow BW (2024) Understanding current experimental models of glioblastoma-brain microenvironment interactions. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-023-04536-8","journal-title":"J Neurooncol"},{"issue":"1","key":"2349_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-025-57225-7","volume":"16","author":"GP Andrieu","year":"2025","unstructured":"Andrieu GP, Simonin M, Cabannes-Hamy A, Lenglin\u00e9 E, Mar\u00e7ais A, Th\u00e9ron A et al (2025) A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancer. Nat Commun 16(1):1\u201315. https:\/\/doi.org\/10.1038\/s41467-025-57225-7","journal-title":"Nat Commun"},{"issue":"12","key":"2349_CR70","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1158\/2159-8290.CD-20-0844\/50264\/P\/TARGETING-METABOLIC-PLASTICITY-AND-FLEXIBILITY","volume":"10","author":"SM Fendt","year":"2020","unstructured":"Fendt SM, Frezza C, Erez A (2020) Targeting metabolic plasticity and flexibility dynamics for cancer therapy. Cancer Discov 10(12):1797\u20131807. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0844\/50264\/P\/TARGETING-METABOLIC-PLASTICITY-AND-FLEXIBILITY. (PubMed PMID: 33139243)","journal-title":"Cancer Discov"},{"issue":"9","key":"2349_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04116-6","volume":"12","author":"K Chen","year":"2021","unstructured":"Chen K, Zhang C, Ling S, Wei R, Wang J, Xu X (2021) The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance. Cell Death Dis 12(9):1\u201312. https:\/\/doi.org\/10.1038\/s41419-021-04116-6","journal-title":"Cell Death Dis"},{"key":"2349_CR72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010459107","author":"SN Vaishnavi","year":"2010","unstructured":"Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME (2010) Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.1010459107","journal-title":"Proc Natl Acad Sci USA"},{"key":"2349_CR73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1303346110","author":"D Tomasi","year":"2013","unstructured":"Tomasi D, Wang GJ, Volkow ND (2013) Energetic cost of brain functional connectivity. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.1303346110","journal-title":"Proc Natl Acad Sci USA"},{"key":"2349_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155794","author":"Z Hao","year":"2024","unstructured":"Hao Z, Wang J, Lv Y, Wu W, Zhang S, Hao S et al (2024) Identification of MGMT promoter methylation as a specific lipid metabolism biomarker, reveals the feasibility of atorvastatin application in glioblastoma. Metabolism. https:\/\/doi.org\/10.1016\/j.metabol.2024.155794","journal-title":"Metabolism"},{"key":"2349_CR75","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c00967","author":"N Wang","year":"2023","unstructured":"Wang N, Wang J, Wang P, Ji N, Yue S (2023) Label-free Raman spectromicroscopy unravels the relationship between MGMT methylation and intracellular lipid accumulation in glioblastoma. Anal Chem. https:\/\/doi.org\/10.1021\/acs.analchem.3c00967","journal-title":"Anal Chem"},{"key":"2349_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2025.100198","author":"KY Koo","year":"2025","unstructured":"Koo KY, Moon K, Song HS, Lee MS (2025) Metabolic regulation by p53: implications for cancer therapy. Mol Cells. https:\/\/doi.org\/10.1016\/j.mocell.2025.100198","journal-title":"Mol Cells"},{"key":"2349_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2018.06.001","author":"CF Labuschagne","year":"2018","unstructured":"Labuschagne CF, Zani F, Vousden KH (2018) Control of metabolism by p53 \u2013 cancer and beyond. Biochim Biophys Acta Rev Cancer. https:\/\/doi.org\/10.1016\/j.bbcan.2018.06.001","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2349_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05625-2","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zhou X, Chen B, Lu M, Wang G, Elumalai N et al (2023) P53 promotes peroxisomal fatty acid \u03b2-oxidation to repress purine biosynthesis and mediate tumor suppression. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-023-05625-2","journal-title":"Cell Death Dis"},{"issue":"1","key":"2349_CR79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-025-01961-w","volume":"13","author":"VO Sviderskiy","year":"2025","unstructured":"Sviderskiy VO, Vasudevaraja V, Dubois LG, Stafford J, Liu EK, Serrano J et al (2025) Metabolic profiling of adult and pediatric gliomas reveals enriched glucose availability in pediatric gliomas and increased fatty acid oxidation in adult gliomas. Acta Neuropathol Commun 13(1):11. https:\/\/doi.org\/10.1186\/s40478-025-01961-w","journal-title":"Acta Neuropathol Commun"},{"key":"2349_CR80","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163448","author":"J Miska","year":"2023","unstructured":"Miska J, Chandel NS (2023) Targeting fatty acid metabolism in glioblastoma. J Clin Investig. https:\/\/doi.org\/10.1172\/JCI163448","journal-title":"J Clin Investig"},{"issue":"15","key":"2349_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2021.663092\/XML","volume":"2","author":"JS So","year":"2021","unstructured":"So JS, Kim H, Han KS (2021) Mechanisms of invasion in glioblastoma: extracellular matrix, Ca2+ Signaling, and glutamate. Front Cell Neurosci 2(15):663092. https:\/\/doi.org\/10.3389\/FNCEL.2021.663092\/XML","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"2349_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2021.683276\/XML","volume":"1","author":"JH Garcia","year":"2021","unstructured":"Garcia JH, Jain S, Aghi MK (2021) Metabolic drivers of invasion in glioblastoma. Front Cell Dev Biol 1(9):683276. https:\/\/doi.org\/10.3389\/FCELL.2021.683276\/XML","journal-title":"Front Cell Dev Biol"},{"issue":"13","key":"2349_CR83","doi-asserted-by":"publisher","first-page":"1340386","DOI":"10.3389\/FONC.2023.1340386\/BIBTEX","volume":"23","author":"N Jovanovich","year":"2023","unstructured":"Jovanovich N, Habib A, Chilukuri A, Hameed NUF, Deng H, Shanahan R et al (2023) Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants. Front Oncol 23(13):1340386. https:\/\/doi.org\/10.3389\/FONC.2023.1340386\/BIBTEX","journal-title":"Front Oncol"},{"issue":"11","key":"2349_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.699594\/BIBTEX","volume":"21","author":"MT Khan","year":"2021","unstructured":"Khan MT, Prajapati B, Lakhina S, Sharma M, Prajapati S, Chosdol K et al (2021) Identification of gender-specific molecular differences in glioblastoma (GBM) and low-grade glioma (LGG) by the analysis of large transcriptomic and epigenomic datasets. Front Oncol 21(11):699594. https:\/\/doi.org\/10.3389\/FONC.2021.699594\/BIBTEX","journal-title":"Front Oncol"},{"key":"2349_CR85","doi-asserted-by":"publisher","DOI":"10.1093\/NOAJNL\/VDAE031","author":"G Cioffi","year":"2024","unstructured":"Cioffi G, Waite KA, Dmukauskas M, Glantz M, Aulakh S, Nicolaides T et al (2024) Sex differences in glioblastoma response to treatment: impact of MGMT methylation. Neurooncol Adv. https:\/\/doi.org\/10.1093\/NOAJNL\/VDAE031","journal-title":"Neurooncol Adv"},{"key":"2349_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-024-00601-7","author":"B Jang","year":"2024","unstructured":"Jang B, Yoon D, Lee JY, Kim J, Hong J, Koo H et al (2024) Integrative multi-omics characterization reveals sex differences in glioblastoma. Biol Sex Differ. https:\/\/doi.org\/10.1186\/s13293-024-00601-7","journal-title":"Biol Sex Differ"},{"issue":"7","key":"2349_CR87","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3390\/CELLS10071783","volume":"10","author":"A Carrano","year":"2021","unstructured":"Carrano A, Juarez JJ, Incontri D, Ibarra A, Cazares HG (2021) Sex-Specific differences in glioblastoma. Cells 10(7):1783. https:\/\/doi.org\/10.3390\/CELLS10071783. (PubMed PMID: 34359952)","journal-title":"Cells"},{"issue":"16","key":"2349_CR88","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2017148118\/SUPPL_FILE\/PNAS.2017148118.SAPP.PDF","volume":"118","author":"N Kfoury","year":"2021","unstructured":"Kfoury N, Qi Z, Prager BC, Wilkinson MN, Broestl L, Berrett KC et al (2021) Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma. Proc Natl Acad Sci USA 118(16):e2017148118. https:\/\/doi.org\/10.1073\/PNAS.2017148118\/SUPPL_FILE\/PNAS.2017148118.SAPP.PDF. (PubMed PMID: 33850013)","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2349_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10040556","volume":"10","author":"A Smits","year":"2021","unstructured":"Smits A, Lysiak M, Magnusson A, Rosell J, S\u00f6derkvist P, Malmstr\u00f6m A (2021) Sex disparities in MGMT promoter methylation and survival in glioblastoma: further evidence from clinical cohorts. J Clin Med 10(4):1\u20137. https:\/\/doi.org\/10.3390\/jcm10040556","journal-title":"J Clin Med"},{"issue":"9","key":"2349_CR90","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3174\/ajnr.A8319","volume":"45","author":"S Gongala","year":"2024","unstructured":"Gongala S, Garcia JA, Korakavi N, Patil N, Akbari H, Sloan A et al (2024) Sex-specific differences in patients with IDH1\u2013wild-type grade 4 glioma in the ReSPOND consortium. Am J Neuroradiol 45(9):1299\u20131307. https:\/\/doi.org\/10.3174\/ajnr.A8319. (PubMed PMID: 38684319)","journal-title":"Am J Neuroradiol"},{"issue":"38","key":"2349_CR91","doi-asserted-by":"publisher","first-page":"19098","DOI":"10.1073\/PNAS.1813495116\/SUPPL_FILE\/PNAS.1813495116.SD04.XLSX","volume":"116","author":"Y Shen","year":"2019","unstructured":"Shen Y, Grisdale CJ, Islam SA, Bose P, Lever J, Zhao EY et al (2019) Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments. Proc Natl Acad Sci USA 116(38):19098\u201319108. https:\/\/doi.org\/10.1073\/PNAS.1813495116\/SUPPL_FILE\/PNAS.1813495116.SD04.XLSX. (PubMed PMID: 31471491)","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2349_CR92","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20231400","volume":"44","author":"J Li","year":"2024","unstructured":"Li J, Wei Y, Liu J, Cheng S, Zhang X, Qiu H et al (2024) Integrative analysis of metabolism subtypes and identification of prognostic metabolism-related genes for glioblastoma. Biosci Rep 44(3):BSR20231400. https:\/\/doi.org\/10.1042\/BSR20231400","journal-title":"Biosci Rep"},{"issue":"2","key":"2349_CR93","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s43018-022-00510-x","volume":"4","author":"S Migliozzi","year":"2023","unstructured":"Migliozzi S, Oh YT, Hasanain M, Garofano L, D\u2019Angelo F, Najac RD et al (2023) Integrative multi-omics networks identify PKC\u03b4 and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy. Nat Cancer 4(2):181\u2013202. https:\/\/doi.org\/10.1038\/s43018-022-00510-x","journal-title":"Nat Cancer"},{"issue":"8","key":"2349_CR94","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41416-020-0993-5","volume":"123","author":"RJ Porter","year":"2020","unstructured":"Porter RJ, Murray GI, McLean MH (2020) Current concepts in tumour-derived organoids. Br J Cancer 123(8):1209\u20131218. https:\/\/doi.org\/10.1038\/s41416-020-0993-5","journal-title":"Br J Cancer"},{"issue":"18","key":"2349_CR95","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/CELLS13181536\/S1","volume":"13","author":"G Ciufolini","year":"2024","unstructured":"Ciufolini G, Zampieri S, Cesaroni S, Pasquale V, Bonanomi M, Gaglio D et al (2024) 3D modeling: insights into the metabolic reprogramming of cholangiocarcinoma cells. Cells 13(18):1536. https:\/\/doi.org\/10.3390\/CELLS13181536\/S1","journal-title":"Cells"},{"issue":"1","key":"2349_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43586-022-00174-y","volume":"2","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Chen X, Dowbaj AM, Sljukic A, Bratlie K, Lin L et al (2022) Organoids. Nat Rev Methods Prim 2(1):1\u201321. https:\/\/doi.org\/10.1038\/s43586-022-00174-y","journal-title":"Nat Rev Methods Prim"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02349-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:40:55Z","timestamp":1781941255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02349-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2349"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02349-0","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the North Rhine Medical Association (\u00a715, ref. 2019033, February 25 2019). Authorization for glioblastoma tissue collection was granted on March 7 2019. All patients provided written informed consent at least 24\u00a0h before surgery. Eligible participants were adults (\u2265\u200918\u00a0years) with suspected WHO grade IV glioblastoma, Karnofsky\u2009\u2265\u200970%, and normal laboratory and organ function. Exclusion criteria included severe comorbidities, immunodeficiency, autoimmune or infectious diseases (HIV, Hepatitis B\/C). Between 2019 and 2022, 36 patients undergoing neurosurgical resection at Sana Kliniken Duisburg were enrolled.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}